2005•Faculty Opinions – Post-Publication Peer Review of the Biomedical LiteratureOpen access

Faculty Opinions recommendation of A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.

Cheng‐Ming Chiang

Open full text 0 citations

Abstract

The peroxisome proliferator-activated receptor γ (PPARγ) plays essential roles in adipogenesis and glucose homeostasis and is a molecular target of insulin-sensitizing drugs 1-3 .Although the ability of PPARγ agonists to antagonize inflammatory responses by transrepression of nuclear factor kappaB (NF-κB) target genes is linked to anti-diabetic 4 and antiatherogenic actions 5 , the mechanisms remain poorly understood.Here we report the identification of a molecular pathway by which PPARγ represses transcriptional activation of inflammatory response genes in macrophages.The initial step of this pathway involves ligand-dependent sumoylation of the PPARγ ligand-binding domain, which targets PPARγ to nuclear receptor co-repressor (NCoR)/histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters.This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation.As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state.This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-κB target genes that regulate immunity and homeostasis.NCoR, and the related factor, silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), are components of corepressor complexes containing HDAC3, transducin beta-like protein-1 (TBL1) and TBLR1 that interact with a subset of unliganded nuclear receptors, mediating active transcriptional repression 6-12 .Ligand-dependent dismissal of these complexes requires Ubc5-dependent ubiquitylation and proteosomal degradation, with Tblr1 functioning as an essential E3 ligase 13 .Recent studies indicate that NCoR/SMRT complexes are also required for basal repression of a subset of NF-κB and AP-1 target genes 13-15 , with loss of NCoR resulting in a partially activated phenotype in macrophages 14 .We noted that a number of inflammatory response genes that are de-repressed in NCoR-deficient macrophages are also subject to transrepression by PPARγ agonists, suggesting a possible role of NCoR in this process.

Open-access reader

About this research paper

What this paper is about

The peroxisome proliferator-activated receptor γ (PPARγ) plays essential roles in adipogenesis and glucose homeostasis and is a molecular target of insulin-sensitizing drugs 1-3 .Although the ability of PPARγ agonists to antagonize inflammatory responses by transrepression of nuclear factor kappaB (NF-κB) target genes is linked to anti-diabetic 4 and antiatherogenic actions 5 , the mechanisms remain poorly understood.Here we report the identification of a molecular pathway by which PPARγ represses transcriptional activation of inflammatory response genes in macrophages.The initial step of this pathway involves ligand-dependent sumoylation of the PPARγ ligand-binding domain, which targets PPARγ to nuclear receptor co-repressor (NCoR)/histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters.This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation.As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state.This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-κB target genes that regulate immunity and homeostasis.NCoR, and the related factor, silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), are components of corepressor complexes containing HDAC3, transducin beta-like protein-1 (TBL1) and TBLR1 that interact with a subset of unliganded nuclear receptors, mediating active transcriptional repression 6-12 .Ligand-dependent dismissal of these complexes requires Ubc5-dependent ubiquitylation and proteosomal degradation, with Tblr1 functioning as an essential E3 ligase 13 .Recent studies indicate that NCoR/SMRT complexes are also required for basal repression of a subset of NF-κB and AP-1 target genes 13-15 , with loss of NCoR resulting in a partially activated phenotype in macrophages 14 .We noted that a number of inflammatory response genes that are de-repressed in NCoR-deficient macrophages are also subject to transrepression by PPARγ agonists, suggesting a possible role of NCoR in this process.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The peroxisome proliferator-activated receptor γ (PPARγ) plays essential roles in adipogenesis and glucose homeostasis and is a molecular target of insulin-sensitizing drugs 1-3 .Although the ability of PPARγ agonists to antagonize inflammatory responses by transrepression of nuclear factor kappaB (NF-κB) target genes is linked to anti-diabetic 4 and antiatherogenic actions 5 , the mechanisms remain poorly understood.Here we report the identification of a molecular pathway by which PPARγ represses transcriptional activation of inflammatory response genes in macrophages.The initial step of this pathway involves ligand-dependent sumoylation of the PPARγ ligand-binding domain, which targets PPARγ to nuclear receptor co-repressor (NCoR)/histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters.This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation.As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state.This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-κB target genes that regulate immunity and homeostasis.NCoR, and the related factor, silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), are components of corepressor complexes containing HDAC3, transducin beta-like protein-1 (TBL1) and TBLR1 that interact with a subset of unliganded nuclear receptors, mediating active transcriptional repression 6-12 .Ligand-dependent dismissal of these complexes requires Ubc5-dependent ubiquitylation and proteosomal degradation, with Tblr1 functioning as an essential E3 ligase 13 .Recent studies indicate that NCoR/SMRT complexes are also required for basal repression of a subset of NF-κB and AP-1 target genes 13-15 , with loss of NCoR resulting in a partially activated phenotype in macrophages 14 .We noted that a number of inflammatory response genes that are de-repressed in NCoR-deficient macrophages are also subject to transrepression by PPARγ agonists, suggesting a possible role of NCoR in this process.

Key concepts: Transrepression, Corepressor, Nuclear receptor, SUMO protein, Transcription factor, Peroxisome proliferator-activated receptor, Nuclear receptor co-repressor 1, Cell biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Faculty Opinions recommendation of A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. — Research Paper | ScholarLens